MiMARK
About:
MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer.
Website: https://www.mimark.es/
Top Investors: CDTI Innovación's INNVIERTE program, EIT Health, Nara Capital, EIC Accelerator, PharmStars
Description:
MiMARK specializes in developing in vitro diagnostic solutions to improve the management of gynecological malignancies. The company envisions the gynecological fluid as the next step in liquid biopsy in gynecology. MiMARK 's first objective is to improve endometrial cancer diagnosis.
Total Funding Amount:
$7.1M
Headquarters Location:
Barcelona, Catalonia, Spain
Founded Date:
2021-01-01
Contact Email:
hello(AT)mimark.es
Founders:
Marina Rigau
Number of Employees:
11-50
Last Funding Date:
2023-11-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai